Loading stock data...
CorMedix Inc. (CRMD) Stock Price, Chart & Analysis
CorMedix Inc.CRMD
Market Closed$14.64
$-0.19-1.28%
CRMD Market Indicators
Very Bullish
Market Sentiment
Historical Price Chart
View the historical price chart for CRMD to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
CorMedix Inc. (CRMD)
Loading chart data...
Is CorMedix Inc. (CRMD) Stock a Buy in 2025?
YES
STRONG BUY
Score: 100/100
Yes, CRMD stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether CRMD stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong profit margins of 42.1%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 39.3% upside potential
Risk Factors
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:2
Hold Ratings:3
Sell Ratings:0
Avg. Price Target:$20.40
Upside Potential:39.3%
Investment Summary
CRMD presents a mixed investment profile for 2025. The company shows strong growth drivers including strong profit margins of 42.1%, though analyst price targets suggest 39.3% upside potential.
Analyst sentiment is generally positive with 2 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly healthcare sector cyclicality, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:100/100
Strong Buy
2030 Price Prediction
Predicted Price:$44.68
Potential Return:+205.2%
Key Factors
- Moderate analyst support
- Significant upside potential
- Exceptional long-term growth potential to 2030
- Good analyst consensus
- Very low debt levels
- Debt-to-Market-Cap Ratio: 0.0% (Very Low)
Investment Decision
Based on our comprehensive analysis of CRMD's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
crmd Stock Price Prediction 2030
Predicted 2030 Price
$44.68
+205.2%from current price
Based on revenue growth analysis and market trends, crmd stock is projected to reach $44.68 by 2030, representing a 205.2% increase from the current price of $14.64.
Current Price
$14.64
Revenue Growth
4829.4%
Analyst Target
$20.40
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in crmd Stock?
Quick Investment Insights for crmd
High Volatility (Beta: 1.71)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
CorMedix Inc.
Healthcare
Biotechnology
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate...
Employees
64
Market Cap
$1.09B